Skip to main content

Table 1 Body and uterine weight in mice fed soy isoflavones and administered LPS.

From: Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease

Treatment Body wt (g) Uterine wt (g)
0 IF Placebo 19.0 ± 0.3 0.12 ± 0.01
0 IF LPS 19.6 ± 0.4 0.11 ± 0.01
126 IF Placebo 19.6 ± 0.2 0.12 ± 0.01
126 IF LPS 19.4 ± 0.3 0.13 ± 0.01
504 IF Placebo 19.7 ± 0.3 0.11 ± 0.01
504 IF LPS 19.7 ± 0.2 0.13 ± 0.01
P value   
LPS 0.4703 0.1457
IF 0.3844 0.4305
LPS*IF 0.3933 0.2276
  1. Mice were fed soy isoflavones (IF; 0, 126 or 504 mg aglycone equivalents of IF/kg diet) for 14-days prior to and during a 30-day exposure to LPS (1.33 μg/d). Results are expressed as means ± standard error.